PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,284 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr | ₹10,756 Cr |
What is the latest Total Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹15,284 Cr |
| Mar2024 | ₹14,925 Cr |
| Mar2023 | ₹14,437 Cr |
| Mar2022 | ₹12,717 Cr |
| Mar2021 | ₹10,756 Cr |
How is Total Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,284 Cr | 2.41 | |
| Mar2024 | ₹14,925 Cr | 3.39 | |
| Mar2023 | ₹14,437 Cr | 13.52 | |
| Mar2022 | ₹12,717 Cr | 18.23 | |
| Mar2021 | ₹10,756 Cr | - | |
Compare Total Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,439.1 Cr | -2.3% | -1.4% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.3% |
-1.4% |
-15.9% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses